William A. Wexler - 15 Nov 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role
Director
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Issuer symbol
CMRA on OTC
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
4
Filing time
17 Nov 2023, 16:13:17 UTC
Previous filing
14 Nov 2023
Next filing
10 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRA Common Stock Other $0 +3,113 +18% $0.000000 20,811 15 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a pro rata distribution to the reporting person by OTR Acquisition Sponsor LLC of the issuer's common stock on November 15, 2023.